Meril says Misso robotic can simplify orthopedic surgical procedures


Take heed to this text

Voiced by Amazon Polly
The Meril Misso surgical robot for simplifying orthopedic procedures.

The Misso robotic will assist surgeons with personalised pre-planning and exact reducing for joint substitute. | Supply: Meril

Meril Life Sciences Pvt. Ltd. this week unveiled its Misso surgical robotic for simplifying orthopedic procedures.

The India-based firm introduced on LinkedIn that it’s growing surgical robotic for whole knee procedures. It mentioned it designed Misso to assist surgeons with personalised pre-planning and exact reducing for joint replacements.

Misso has an optical monitoring sensor, a six-axis articulated robotic arm, and “superior” security techniques, claimed Meril. The surgical robotic will help physicians carry out real-time hole checks and modify a surgical plan intraoperatively, it defined.

Varied reducing choices can be found on the Misso, together with full and partial reducing based mostly on surgeon desire. Slicing guides will not be required, and the system can carry out a tibial minimize and a completely completed femur with all of the cuts, together with peg holes, based on the firm.

Misso consists of security options

Meril designed Misso with bone-movement monitoring to make sure security throughout procedures. If bone motion is noticed, the resection course of stops.

The resection will proceed with automated restoration of the bone place. If the robotic system’s instruments contact the affected person or different object, the collaborative robotic arm will instantly cease transferring.

Misso makes use of optical tracking-based navigation and robotic help to make sure correct leads to shaping and aligning synthetic knee joint elements. The corporate goals to enhance post-operative outcomes, cut back issues, and promote quicker affected person restoration.

Meril joins aggressive surgical robotic market

Based in 2006, Meril mentioned it’s devoted to the innovation, design, and improvement of novel, clinically related gadgets. Its product portfolio consists of vascular intervention gadgets, orthopedic implants, robotics, endo-surgery, ENT merchandise, and in-vitro diagnostics. 

The corporate has joined the rising surgical robotics market, the place it’ll compete with orthopedic surgical robotic builders similar to Stryker and Zimmer Biomet. Stryker launched its its Mako surgical robotic in 2017 and launched a joint-replacement providing in February 2024.

Additionally in February, the U.S. Meals and Drug Administration (FDA) cleared Zimmer Biomet’s Rosa surgical robotic platform for shoulder and hip substitute procedures. The FDA had cleared it for partial knee substitute for partial knee substitute in April 2021.

Editor’s word: This text is syndicated from The Robotic Report sibling web site MassDevice.